Stephen E. Straus, MD; Jeffrey I. Cohen, MD; Giovanna Tosato, MD; Jeffery Meier, MD
Epstein-Barr virus (EBV) encodes genes that ensure its persistence in human B lymphocytes. Some of the genes encourage B-cell proliferation; others are poised to evade or defeat immune recognition. Immune restraints on the virus, however, are typically so effective that most infections are never symptomatic. In contrast, acute infectious mononucleosis, a self-limited lymphoproliferative illness, is common in adolescents and young adults. Unbridled proliferative illnesses arise when cellular immunity is grossly defective. Treatment of EBV-associated syndromes is largely supportive. Antiviral drugs have no proven role except in patients with oral hairy leukoplakia. Vaccine development is technically feasible but is not considered a high priority for developed nations.
The genome consists of about 172 000 base pairs of double-stranded DNA (top line) that are organized in a series of unique (U1 to U5), internal repeat (IR1 to IR4), and terminal repeat (TR) domains (second line). Shorter repeated regions occur but are not shown. Several of the Epstein-Barr virus genes expressed during the viral replication cycle (third line) and during viral latency in B lymphocytes (fourth line) are depicted. The coding regions of EBNA (Epstein-Barr virus nuclear antigen)-LP, LMP (latent membrane protein)-1, and LMP-2A and LMP-2B are spliced (-o) from discontinuous portions of the genome; LMP-2A and LMP-2B begin at the right end of the circularized genome and extend across the terminal repeats to the left end of the genome. EBERs = Epstein-Barr virus encoded RNAs; ZEBRA = Z Epstein-Barr virus replication activator.
Specimens were stained with monoclonal antibody to Epstein-Barr virus nuclear antigen 2 (EBNA-2) or latent membrane protein 1 (LMP-1) (bottom panel). Note the nuclear staining with nucleolar exclusion with EBNA-2 antibody and cytoplasmic membrane staining with LMP-1 antibody. Reproduced with permission from Gilligan and colleagues and Cohen .
The geometric mean is indicated by the horizontal bar.
The T cells were cultured for 3 days in phytohemagglutinin (PHA), 0.5 µg/mL, either alone or with interleukin-10, 0.1 to 10 U/mL. Proliferation was measured as counts per minute (cpm) of Hydrogen-3-thymidine incorporation during the final 18 hours of culture. IL = interleukin.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Straus SE, Cohen JI, Tosato G, et al. Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management. Ann Intern Med. 1993;118:45–58. doi: https://doi.org/10.7326/0003-4819-118-1-199301010-00009
Download citation file:
Published: Ann Intern Med. 1993;118(1):45-58.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use